Skip to content
April 25, 2024

Equity.Guru

Investment information for the new generation

Search

News Summary

Curaleaf (CURA.C), the CSE-listed, U.S.-based multi-state operator (MSO), is now the target of several class-action lawsuits concerning the sale of products in violation of FDA regulations. Lawsuits by at…
For the first time since 2008, the Fed cut rates by 25 basis points to boost economic growth. In a perfect world, a lower cost of borrowing would’ve made…
Namaste Technologies (N.V), cannabis’ favourite red-headed stepchild, hasn’t been having the best run lately, and being ordered to pay nearly USD$5M in cross-border settlements is just the chef’s kiss….
Beyond Meat (BYND.Q), the vegan burger maker we all know and love, has partnered with Dunkin’ Brands’ Group (DNKN.Q) to add its plant-based sausages to Dunkin’ Donuts menus in Manhattan, but…
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused…
The investigation via special committee of CannTrust Holdings’ (TRST.C) non-compliance with Health Canada mandated regulations is ongoing, with further information regarding the committee’s membership now available. On July 11,…
Aurora Cannabis (ACB.T) has been named as the sole winner in the Italian medical cannabis tender process, an announcement tempered by worries over the company’s mounting debt and disappointing revenue….
Winning sports teams rarely fire their managers. Losing ones always do. Sometimes a new manager can reverse the fortunes of a losing team. Example: When $3.1 billion Manchester United fired…
Another day another board resignation at Wayland Group (WAYL.C) headquarters, but what else is new. The company has gone quiet over the past month and a half and its last news…
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year…